MedTrace Logo

Blood Microbiota Signature of Alzheimer's Disease

NCT04841135 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2023-04-20

No results posted yet for this study

Summary

This study aims to validate a difference in blood microbial signature between Alzheimer's patients and control subjects in order to propose potential innovative strategies

Conditions

  • Alzheimer Disease
  • Elderly With Normal Cognition

Interventions

OTHER

Multiomics quantification

One time blood, stool and urine samples will be taken.

OTHER

Polysomnography

Facultative polysomnography

Sponsors & Collaborators

  • University Hospital, Montpellier

    lead OTHER

Principal Investigators

  • Karim BENNYS, MD, PhD · Montpellier University Hospital

Study Design

Allocation
NON_RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
50 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-06-03
Primary Completion
2024-04-30
Completion
2026-01-31

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04841135 on ClinicalTrials.gov